title: Diabetic neuropathy.
abstract: Neuropathies related to diabetes mellitus can affect 60-70% of patients with diabetes. These can include peripheral polyneuropathies, mononeuropathies, and autonomic neuropathies. Control of glucose, lipids, and hypertension and cessation of smoking can limit onset and progression of these neuropathies. Besides control of the above listed risk factors, we do not have effective medications to treat the pathophysiologic mechanisms of diabetic neuropathies. Treatment is limited to ameliorating pain and correcting the end organ consequences of the neuropathic processes.
authors.affiliation: Division of Endocrinology and Metabolism, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA. Electronic address: gcharno@lumc.edu.
authors.forename: Gerald
authors.initials: G
authors.lastname: Charnogursky
authors.affiliation: Division of Endocrinology and Metabolism, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA.
authors.forename: Hong
authors.initials: H
authors.lastname: Lee
authors.affiliation: Division of Endocrinology and Metabolism, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA.
authors.forename: Norma
authors.initials: N
authors.lastname: Lopez
mesh_terms: D003929:Diabetic Neuropathies / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D012307:Risk Factors
keywords: Peripheral neuropathy; autonomic neuropathy; diabetic complications; mononeuropathy; polyneuropathy